Shares of Oscar Health Inc. (NYSE:OSCR) are trading higher Thursday morning as Wall Street analysts raised price targets following the company’s 2026 Investor Day presentation. Here’s what investors need to know.
- Oscar Health shares are trending higher. What’s driving OSCR shares up?
Wall Street Bullishness Follows Investor Day Execution
A primary catalyst behind Thursday morning’s upward movement is a series of sell-side research updates published ahead of the market open. Barclays maintained an Overweight rating on Oscar Health while raising the firm’s price target to $49.
Concurrently, Baird maintained its Neutral rating while raising its price target to $33 and Stephens & Co. reiterated an Equal-Weight rating with a $34 price target.
Upgraded Full-Year 2026 Profitability Outlook
The wave of positive analyst updates follows an SEC Form 8-K filed on Wednesday, detailing material improvements to Oscar’s full-year 2026 financial guidance unveiled during its Investor Day. Management raised its expected Earnings from Operations by $100 million to a new target range of $600 million to $800 million, up from previous expectations of $500 million to $700 million.
Additionally, Oscar improved its full-year Medical Loss Ratio expectation by 50 basis points to a range of 81.0% to 82.0%, compared to its prior range of 81.5% to 82.5%, signaling stronger underwriting efficiency. Alongside the upgraded earnings metrics, the company reaffirmed its full-year 2026 total revenue guidance of $18.7 billion to $19.0 billion and an SG&A expense ratio target between 15.6% and 16.1%.
OSCR Shares Rise Thursday Morning
OSCR Price Action: Oscar Health shares were up 2.38% at $33.11 at the time of publication on Thursday. The stock is approaching its 52-week high of $34.47, according to Benzinga Pro data.
Image: Shutterstock
Login to comment